IBEX Limited (IBEX) Stock Overview
Explore IBEX Limited’s financial performance, market position, analyst ratings, and future outlook.
IBEX Limited (IBEX)
Key Financials
Key Financials
Market Cap
594M
P/E Ratio
12.99
EPS (TTM)
$3.55
ROE
0.29%
IBEX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of IBEX Limited (NASDAQ: IBEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IBEX Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IBEX on the NASDAQ shows an RSI of 51.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $41.47 for the NASDAQ listing.
Key metrics behind IBEX Limited's NASDAQ-traded stock include a P/E ratio of 12.99 and a market capitalization of 594M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBEX on the NASDAQ.